JP2005504120A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504120A5
JP2005504120A5 JP2003532440A JP2003532440A JP2005504120A5 JP 2005504120 A5 JP2005504120 A5 JP 2005504120A5 JP 2003532440 A JP2003532440 A JP 2003532440A JP 2003532440 A JP2003532440 A JP 2003532440A JP 2005504120 A5 JP2005504120 A5 JP 2005504120A5
Authority
JP
Japan
Prior art keywords
benzonitrile
phenoxy
chloro
methylaminomethyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003532440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504120A (ja
Filing date
Publication date
Priority claimed from SE0103325A external-priority patent/SE0103325D0/xx
Application filed filed Critical
Publication of JP2005504120A publication Critical patent/JP2005504120A/ja
Publication of JP2005504120A5 publication Critical patent/JP2005504120A5/ja
Pending legal-status Critical Current

Links

JP2003532440A 2001-10-04 2002-10-02 新規な化合物 Pending JP2005504120A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103325A SE0103325D0 (sv) 2001-10-04 2001-10-04 Novel compounds
PCT/SE2002/001803 WO2003029185A1 (en) 2001-10-04 2002-10-02 Novel compounds

Publications (2)

Publication Number Publication Date
JP2005504120A JP2005504120A (ja) 2005-02-10
JP2005504120A5 true JP2005504120A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2006-01-05

Family

ID=20285562

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003532440A Pending JP2005504120A (ja) 2001-10-04 2002-10-02 新規な化合物

Country Status (5)

Country Link
US (2) US7119122B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1434756A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2005504120A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE0103325D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2003029185A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227974A9 (en) * 2002-08-01 2005-10-13 Euro-Celtique S.A. Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers
WO2007108004A2 (en) * 2006-03-23 2007-09-27 Meditor Pharmaceuticals Ltd. S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
WO2012090177A2 (en) * 2010-12-30 2012-07-05 Lupin Limited Cannabinoid receptor modulators
WO2013005168A2 (en) * 2011-07-05 2013-01-10 Lupin Limited Cannabinoid receptor modulators
GB201512635D0 (en) 2015-07-17 2015-08-26 Ucl Business Plc Uses of therapeutic compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE363818B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1968-08-15 1974-02-04 Lilly Co Eli
FI874121A7 (fi) * 1986-09-24 1988-03-25 Sumitomo Chemical Co Heterocykliska foereningar, och deras framstaellning och anvaendning.
GB9215921D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Anti-inflammatory compounds
CZ293595A3 (cs) 1995-11-09 1999-12-15 Farmak A. S. Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích
US7160887B1 (en) * 1998-10-20 2007-01-09 Takeda Pharmaceutical Company Limited Aromatic amine derivatives, their production and use
BR0015578A (pt) 1999-11-15 2002-07-09 Lilly Co Eli Arilóxi propanolaminas para melhorar a produção de rebanhos
JP4988128B2 (ja) 2000-07-13 2012-08-01 イーライ リリー アンド カンパニー β3アドレナリン作動性アゴニスト

Similar Documents

Publication Publication Date Title
RU2498983C2 (ru) Соединения фениламинопиримидина и их применения
RU2386626C2 (ru) 1a, 5a-ТЕТРАГИДРО-S-ТИАЦИКЛОПРОПА[a]ПЕНТАЛЕНЫ:ТРИЦИКЛИЧЕСКИЕ ПРОИЗВОДНЫЕ ТИОФЕНА В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРОВ S1P1/EDG1
TW555735B (en) Diarylpropylamines, methods for their preparation and pharmaceutical compositions containing them
JP2020506171A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU2494089C2 (ru) Соединения, представляющие собой стиролильные производные, для лечения офтальмических заболеваний и расстройств
CA2428039A1 (en) Serotonergic agents
CA2601508A1 (en) Cyclopropanecarboxamide derivatives
RU2336267C2 (ru) Производные пирролидона в качестве ингибиторов маов
US20050245519A1 (en) Substituted morpholine compounds for the treatment of central nervous system disorders
NZ334215A (en) Aralkyl and aralkylidene heterocyclic lactams and imides useful as psychotherapeutic agents
RU2006107653A (ru) Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли
CA2518932A1 (en) 2,4-di(phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
JP2012515166A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU2019136279A (ru) C5 -Анилинохиназолиновые соединения и их использование в лечении рака
RU2013127155A (ru) Новые замещенные бициклические ароматические соединения в качестве ингибиторов s-нитрозоглутатион-редуктазы
RU2014101464A (ru) Циклопропил-конденсированные-1,3-тиазепины в качестве ингибиторов васе 1 и(или) васе 2
HUE024898T2 (en) New pyrimidine compound with dibenzylamine structure and drug containing compound
JP2005506308A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2010524975A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2010500345A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2005504120A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2017535515A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2007515467A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2005501847A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA2449854A1 (en) Aminoacetonitrile compounds for controlling endoparasites